thiophenes has been researched along with leupeptins in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Itoh, K; Kensler, TW; Kwak, MK; Yamamoto, M | 1 |
Body, JJ; Journé, F; Laurent, G; Leclercq, G; Nonclercq, D | 1 |
Ding, J; Feng, JM; Miao, ZH; Zhang, XW; Zhu, H | 1 |
Alcantara, SL; Brzozowski, MJ; Iravani, MM; Jenner, P; Rose, S | 1 |
Cao, H; Chen, X; Guan, S; He, B; Li, Y; Shi, C; Wang, J; Xu, X; Zhang, S | 1 |
Jeong, J; Lee, KH; Yoo, CG | 1 |
6 other study(ies) available for thiophenes and leupeptins
Article | Year |
---|---|
Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cataract; Cell Line; Cell Nucleus; Cysteine Endopeptidases; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Gene Expression Regulation; Genes, Reporter; Leupeptins; Mice; Multienzyme Complexes; Mutagenesis, Site-Directed; NF-E2-Related Factor 2; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Response Elements; RNA, Messenger; Thiones; Thiophenes; Trans-Activators; Transcription, Genetic | 2002 |
Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.
Topics: Breast Neoplasms; Cycloheximide; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Lactones; Leupeptins; Ligands; Macrolides; Molecular Chaperones; Proteasome Inhibitors; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Pyrrolidines; Signal Transduction; Tamoxifen; Thiophenes; Tumor Cells, Cultured | 2004 |
Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Checkpoint Kinase 1; Enzyme Inhibitors; Flow Cytometry; HSP90 Heat-Shock Proteins; Humans; Leupeptins; Naphthalimides; Proteasome Endopeptidase Complex; Protein Kinases; Thiophenes; Time Factors; Topoisomerase II Inhibitors; Ubiquitin | 2008 |
The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amidines; Animals; Asparagine; Caspase 3; Cell Death; Cell Line, Tumor; Citrulline; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indazoles; L-Lactate Dehydrogenase; Leupeptins; Mice; Neuroblastoma; Neurotoxins; Nitric Oxide Synthase Type I; Thiophenes; Transfection; Tritium; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2011 |
Cyclooxygenase-2 regulated by the nuclear factor-κB pathway plays an important role in endometrial breakdown in a female mouse menstrual-like model.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Decidua; Endometrium; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Indomethacin; Leupeptins; Menstruation; Mice; Mice, Inbred C57BL; Models, Animal; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiocarbamates; Thiophenes | 2013 |
Long-term incubation with proteasome inhibitors (PIs) induces IκBα degradation via the lysosomal pathway in an IκB kinase (IKK)-dependent and IKK-independent manner.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Dipeptides; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; I-kappa B Kinase; I-kappa B Proteins; Interleukin-8; Ketones; Leupeptins; Lysosomes; Microtubule-Associated Proteins; Mutation, Missense; NF-kappa B; NF-KappaB Inhibitor alpha; Proteasome Inhibitors; Proteolysis; Pyrazines; Thiophenes; Time Factors | 2013 |